60923-227-02 : NDC 2026 Code

60923-227-02 : Casimersen ( Amondys 45 )

Additionally :

You can get information about “60923-227-02” NDC code in 60923-227-02 in HTML format

HTML | 60923-227-02 in TXT (Plain Text) format

TXT | 60923-227-02 in PDF (Portable Document Format)

PDF | 60923-227-02 in XML format

XML formats.

NDC Code : 60923-227-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "60923-227-02",
    "PackageDescription": "1 VIAL, SINGLE-USE in 1 CARTON (60923-227-02)  / 2 mL in 1 VIAL, SINGLE-USE",
    "NDC11Code": "60923-0227-02",
    "ProductNDC": "60923-227",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Amondys 45",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Casimersen",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20210225",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA213026",
    "LabelerName": "Sarepta Therapeutics, Inc.",
    "SubstanceName": "CASIMERSEN",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Antisense Oligonucleotide [EPC], Increased Protein Synthesis [PE], Oligonucleotides, Antisense [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20210225",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}